Oral Presentation 3

[OP3-05] The impact of Upfront combination therapy in patients with mCSPC on OS after mCRPC: a multicentre retrospective study

*Toshikazu Tanaka¹, Shingo Hatakeyama², Naoki Fujita³, Teppei Okamoto³, Hayato Yamamoto³, Takahiro Yoneyama⁴, Yasuhiro Hashimoto³, Chikara Ohyama^2,3,4 (1. Aomori prefectural central hospital, Department of Urology, 2. Department of Advanced Blood Purification Therapy, Hirosaki University Graduate School of Medicine, 3. Department of Urology, Hirosaki University Graduate School of Medicine, 4. Department of Advanced Transplant and Regenerative Medicine, Hirosaki University Graduate School of Medicine)